Net Income

A new class action lawsuit accuses medical device firm Integer Holdings of hiding poor sales while touting growth, leading to a major stock drop.

Fortune 500 giant ARKO Corp. plans to take its petroleum wholesale business public, a strategic split aimed at unlocking value and focusing growth.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

A trio of real estate giants will build a massive rental complex in Vieux-Longueuil, a major move to address the South Shore's critical housing shortage.

The powerboat giant expands its share repurchase in a show of financial strength, betting on long-term recovery despite a soft recreational market.

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

Nova Minerals is raising $20M to advance its Estelle Project, a key Alaskan site for gold and the strategically vital mineral antimony amid global supply woes.

Following PwC's resignation, the private credit firm's move to MNP signals a new chapter in its financial governance as it streamlines operations.

In a fierce biotech talent war, Senti Bio's new equity grant for a key hire signals a strategic push for its gene therapy pipeline amid market volatility.

The sustainable materials firm saw net income jump 60% after a planned shutdown created a record backlog, setting the stage for a strong Q3.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

WhiteFiber lands a 10-year, 40 MW anchor deal with AI provider Nscale, validating its high-density strategy and fueling North Carolina's tech boom.

As Applied Digital preps its Q2 results, investors watch to see if its multi-billion dollar contracts can quell market volatility and affirm its AI future.

The U.S. government is partnering with 24 tech leaders, including Accenture, on a mission to double R&D and secure global leadership in AI.

Facing a critical cash shortfall, Cue Biopharma turns to the market, betting its promising cancer and autoimmune pipeline can win over investors.

An executive order accelerates moving cannabis to Schedule III, promising massive tax breaks for businesses but leaving advocates wanting more federal reform.

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

National homebuilder Toll Brothers opens Bethany Farms in Simpsonville, tapping into the area's hot luxury market with customizable homes and amenities.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.